Skip to main content
. 2020 Sep 18;12(9):888. doi: 10.3390/pharmaceutics12090888

Figure 1.

Figure 1

(A) Structure of peptides for virus-like nanoparticles formation. (A) Sp-CC-PEG, Reproduced with permission from [81], American Chemical Society, 2013. (B) K3C6SPD with the sequence of KKKC6WLVFFAQQGSPD. Reproduced with permission from [80], American Chemical Society, 2014.